BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31910649)

  • 1. OUTSMART HF: A Randomized Controlled Trial of Routine Versus Selective Cardiac Magnetic Resonance for Patients With Nonischemic Heart Failure (IMAGE-HF 1B).
    Paterson DI; Wells G; Erthal F; Mielniczuk L; O'Meara E; White J; Connelly KA; Knuuti J; Radja M; Laine M; Chow BJW; Kandolin R; Chen L; Dick A; Dennie C; Garrard L; Ezekowitz J; Beanlands R; Chan KL;
    Circulation; 2020 Mar; 141(10):818-827. PubMed ID: 31910649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routine versus selective cardiac magnetic resonance in non-ischemic heart failure - OUTSMART-HF: study protocol for a randomized controlled trial (IMAGE-HF (heart failure) project 1-B).
    Paterson I; Wells GA; Ezekowitz JA; White JA; Friedrich MG; Mielniczuk LM; O'Meara E; Chow B; DeKemp RA; Klein R; Dennie C; Dick A; Coyle D; Dwivedi G; Rajda M; Wright GA; Laine M; Hanninen H; Larose E; Connelly KA; Leong-Poi H; Howarth AG; Davies RA; Duchesne L; Yla-Herttuala S; Saraste A; Farand P; Garrard L; Tardif JC; Arnold M; Knuuti J; Beanlands R; Chan KL
    Trials; 2013 Oct; 14():332. PubMed ID: 24119686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of cardiac magnetic resonance imaging on heart failure patients referred to a tertiary advanced heart failure unit: improvements in diagnosis and management.
    Lum YH; McKenzie S; Brown M; Hamilton-Craig C
    Intern Med J; 2019 Feb; 49(2):203-211. PubMed ID: 30152581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of myocardial iron deficiency in nonischemic heart failure by cardiac T2* magnetic resonance imaging.
    Nagao M; Matsuo Y; Kamitani T; Yonezawa M; Yamasaki Y; Kawanami S; Abe K; Mukai Y; Higo T; Yabuuchi H; Takemura A; Yoshiura T; Sunagawa K; Honda H
    Am J Cardiol; 2014 Mar; 113(6):1024-30. PubMed ID: 24461766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial.
    O'Meara E; Mielniczuk LM; Wells GA; deKemp RA; Klein R; Coyle D; Mc Ardle B; Paterson I; White JA; Arnold M; Friedrich MG; Larose E; Dick A; Chow B; Dennie C; Haddad H; Ruddy T; Ukkonen H; Wisenberg G; Cantin B; Pibarot P; Freeman M; Turcotte E; Connelly K; Clarke J; Williams K; Racine N; Garrard L; Tardif JC; DaSilva J; Knuuti J; Beanlands R;
    Trials; 2013 Jul; 14():218. PubMed ID: 23866673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraventricular dyssynchrony predicts mortality and morbidity after cardiac resynchronization therapy: a study using cardiovascular magnetic resonance tissue synchronization imaging.
    Chalil S; Stegemann B; Muhyaldeen S; Khadjooi K; Smith RE; Jordan PJ; Leyva F
    J Am Coll Cardiol; 2007 Jul; 50(3):243-52. PubMed ID: 17631217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy.
    Shen L; Ramires F; Martinez F; Bodanese LC; Echeverría LE; Gómez EA; Abraham WT; Dickstein K; Køber L; Packer M; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Jhund PS; Gimpelewicz CR; McMurray JJV;
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29141857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure.
    Yoshida A; Ishibashi-Ueda H; Yamada N; Kanzaki H; Hasegawa T; Takahama H; Amaki M; Asakura M; Kitakaze M
    Eur J Heart Fail; 2013 Feb; 15(2):166-75. PubMed ID: 23329703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of pulmonary vascular resistance estimated by cardiac magnetic resonance in patients with chronic heart failure.
    Fabregat-Andrés Ó; Estornell-Erill J; Ridocci-Soriano F; García-González P; Bochard-Villanueva B; Cubillos-Arango A; Espriella-Juan Rde L; Fácila L; Morell S; Cortijo J
    Eur Heart J Cardiovasc Imaging; 2014 Dec; 15(12):1391-9. PubMed ID: 25104808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure.
    Puntmann VO; Carr-White G; Jabbour A; Yu CY; Gebker R; Kelle S; Hinojar R; Doltra A; Varma N; Child N; Rogers T; Suna G; Arroyo Ucar E; Goodman B; Khan S; Dabir D; Herrmann E; Zeiher AM; Nagel E;
    JACC Cardiovasc Imaging; 2016 Jan; 9(1):40-50. PubMed ID: 26762873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized Prognosis Assessment in ST-Segment-Elevation Myocardial Infarction Using a Cardiac Magnetic Resonance Imaging Risk Score.
    Stiermaier T; Jobs A; de Waha S; Fuernau G; Pöss J; Desch S; Thiele H; Eitel I
    Circ Cardiovasc Imaging; 2017 Nov; 10(11):. PubMed ID: 29122844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.
    Feldman T; Mauri L; Kahwash R; Litwin S; Ricciardi MJ; van der Harst P; Penicka M; Fail PS; Kaye DM; Petrie MC; Basuray A; Hummel SL; Forde-McLean R; Nielsen CD; Lilly S; Massaro JM; Burkhoff D; Shah SJ;
    Circulation; 2018 Jan; 137(4):364-375. PubMed ID: 29142012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy: results of the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region trial.
    Saba S; Marek J; Schwartzman D; Jain S; Adelstein E; White P; Oyenuga OA; Onishi T; Soman P; Gorcsan J
    Circ Heart Fail; 2013 May; 6(3):427-34. PubMed ID: 23476053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and design of a randomized controlled trial of allogeneic mesenchymal stem cells in patients with nonischemic cardiomyopathy.
    Greene SJ; Epstein SE; Kim RJ; Quyyumi AA; Cole RT; Anderson AS; Wilcox JE; Skopicki HA; Sikora S; Verkh L; Tankovich NI; Gheorghiade M; Butler J
    J Cardiovasc Med (Hagerstown); 2017 Apr; 18(4):283-290. PubMed ID: 26479144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized study of cardiac resynchronization therapy defibrillator versus dual-chamber implantable cardioverter-defibrillator in ischemic cardiomyopathy with narrow QRS: the NARROW-CRT study.
    Muto C; Solimene F; Gallo P; Nastasi M; La Rosa C; Calvanese R; Iengo R; Canciello M; Sangiuolo R; Diemberger I; Ciardiello C; Tuccillo B
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):538-45. PubMed ID: 23592833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclinical Atherosclerosis, Cardiac and Kidney Function, Heart Failure, and Dementia in the Very Elderly.
    Kuller LH; Lopez OL; Gottdiener JS; Kitzman DW; Becker JT; Chang Y; Newman AB
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.
    Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M
    Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and Prognostic Utility of Cardiac Magnetic Resonance Imaging in Aortic Regurgitation.
    Kammerlander AA; Wiesinger M; Duca F; Aschauer S; Binder C; Zotter Tufaro C; Nitsche C; Badre-Eslam R; Schönbauer R; Bartko P; Beitzke D; Loewe C; Hengstenberg C; Bonderman D; Mascherbauer J
    JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 1):1474-1483. PubMed ID: 30448117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis assessment of cardiac involvement in systemic AL amyloidosis by magnetic resonance imaging.
    Mekinian A; Lions C; Leleu X; Duhamel A; Lamblin N; Coiteux V; De Groote P; Hatron PY; Facon T; Beregi JP; Hachulla E; Launay D;
    Am J Med; 2010 Sep; 123(9):864-8. PubMed ID: 20800158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac resynchronization therapy guided by cardiac magnetic resonance imaging: A prospective, single-centre randomized study (CMR-CRT).
    Kočková R; Sedláček K; Wichterle D; Šikula V; Tintěra J; Jansová H; Pravečková A; Langová R; Krýže L; El-Husseini W; Segeťová M; Kautzner J
    Int J Cardiol; 2018 Nov; 270():325-330. PubMed ID: 29908832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.